Clofarabine Combinations in Adults with Refractory/Relapsed Acute Lymphoblastic Leukemia (ALL): A GRAALL Report

被引：0
|
作者：
Pigneux, Arnaud [1 ]
Sauvezie, Mathieu [2 ]
Vey, Norbert [3 ]
Raffoux, Emmanuel
Marcais, Ambroise
Huguet, Francoise [5 ]
Rousselot, Philippe [6 ]
Marolleau, Jean Pierre [7 ]
Lepretre, Stephane [8 ]
Turlure, Pascal [9 ]
Chevallier, Patrice [10 ]
Hunault, Mathilde [11 ]
Bonmati, Caroline [12 ]
Cluzeau, Thomas [13 ]
Leguay, Thibaut [14 ]
Ifrah, Norbert [11 ]
Dombret, Herve [4 ]
机构：
[1] CHU Bordeaux, Pessac, France
[2] Hop Haut Leveque, Serv Hematol Clin & Therapie Cellulaire, Pessac, France
[3] Univ Marseille, Inst J Paoli I Calmettes, Marseille, France
[4] Univ Paris 07, Hop St Louis, AP HP, EA 3518, Paris, France
[5] Univ Toulouse, Hop Purpan, Toulouse, France
[6] Univ Versailles St Quentin Yvelines, Hop Versailles, Le Chesnay, France
[7] Hop SUD, Hematol Unit, Amiens 1, France
[8] Ctr Henri Becquerel, F-76038 Rouen, France
[9] Univ Limoges, CHU Dupuytren, Limoges, France
[10] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[11] CHU Angers, Serv Hematol, Angers, France
[12] Hop Brabois, Vandoeuvre Les Nancy, France
[13] CHU Archet, Serv Hematol, Nice, France
[14] Univ Bordeaux, Hop Haut Leveque, Pessac, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1110 / 1110
页数：1
相关论文
共 50 条
  • [41] Clofarabine for the treatment of acute lymphoblastic leukemia
    Jeha, Sima
    Kantarjian, Hagop
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (02) : 113 - 118
  • [42] Phase I Results of Mitoxantrone in Combination with Clofarabine in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia
    Hochberg, J.
    Oesterheld, J.
    Militano, O.
    Klejmont, L.
    Harrison, L.
    Nickerson, B.
    Cairo, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S108 - S108
  • [43] Inotuzumab Ozogamicin (Besponsa®) for Patients with relapsed or refractory acute lymphoblastic Leukemia (r/r ALL)
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (1-2) : 66 - 66
  • [44] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali
    Rodriguez, Vilmarie
    O'Brien, Maureen Megan
    McNeer, Jennifer Lynn
    Loh, Mignon L.
    Rheingold, Susan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions
    Aldoss, Ibrahim
    Yang, Dongyun
    Afkhami, Michelle
    Gu, Zhaohui
    Mokhtari, Sally
    Shahani, Shilpa
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Koller, Paul B.
    Tomasian, Vanina
    Telatar, Milhan
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Ball, Brian J.
    Otoukesh, Salman
    Amanam, Idoroenyi
    Artz, Andrew S.
    Becker, Pamela S.
    Stewart, Forrest M.
    Curtin, Peter T.
    Pillai, Raju
    Smith, Eileen P.
    Marcucci, Guido
    Stein, Anthony S.
    Forman, Stephen J.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    BLOOD, 2022, 140 : 6020 - 6022
  • [46] Safety and efficacy of marqibo (vincristine sulfate liposomes injection, OPTISOME™) in for the treatment of adults with relapsed or refractory acute lymphoblastic leukemia (ALL)
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Stock, Wendy
    Heffner, Leonard
    Tredinnick, Alexandra
    Lu, Baio
    Choy, Gavin S.
    Deitcher, Steven R.
    O'Brien, Susan M.
    BLOOD, 2007, 110 (11) : 263A - 263A
  • [47] Patient Characteristics and Treatment Patterns in Elderly Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia Using 100% Medicare ALL Data
    Chia, Victoria
    Molony, Julia T.
    Li, Shuling
    Katz, Aaron Jacob
    BLOOD, 2016, 128 (22)
  • [48] The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia
    Benjamin, Jonathan E.
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 142 - 156
  • [49] BIOV-111 a European phase II trial of clofarabine (Evoltra® in refractory and relapsed childhood acute lymphoblastic leukemia.
    Kearns, Pamela
    Michel, Gerard
    Nelken, Brigitte
    Joel, Simon
    Al-Ghazaly, Essam
    Beishuizen, Auke
    Conter, Valentino
    Gadner, Helmut
    Henze, Gunter
    Smith, Hazel
    Baruchel, Andre
    Saha, Vaskar
    BLOOD, 2006, 108 (11) : 527A - 527A
  • [50] Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma
    Candoni, Anna
    Lazzarotto, Davide
    Petruzzellis, Giuseppe
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 751 - 756
12345